iman aboudalle (@imanaboudalle) 's Twitter Profile
iman aboudalle

@imanaboudalle

Hematologist @AUBMC. MDACC alumni. Tweets are my own.

ID: 1067207453228625920

calendar_today27-11-2018 00:04:19

94 Tweet

423 Followers

263 Following

iman aboudalle (@imanaboudalle) 's Twitter Profile Photo

Look at these straight curves for favorable AML treated with Cladribine/LDAC-VEN alt AZA-VEN regimen in older patients 😍 I think we able to cure them 🎉 Tapan Kadia Hagop Kantarjian,MD

Look at these straight curves for favorable AML treated with Cladribine/LDAC-VEN alt AZA-VEN regimen in older patients 😍 I think we able to cure them 🎉 <a href="/TapKadia/">Tapan Kadia</a> <a href="/DrHKantarjian/">Hagop Kantarjian,MD</a>
iman aboudalle (@imanaboudalle) 's Twitter Profile Photo

🟢 Moving forward beyond AZA-VEN in AML with triple combinations. Cuzatuzumab, anti-CD70 antibody looks safe and promising 👍🏻👍🏻

🟢 Moving forward beyond AZA-VEN in AML with triple combinations. Cuzatuzumab, anti-CD70 antibody looks safe and promising 👍🏻👍🏻
iman aboudalle (@imanaboudalle) 's Twitter Profile Photo

✅ Another monoclonal antibodies in combinations with AZA-VEN 💡Magrolimab and IMGN632 in AML.. Looking forward for phase 3 trials showing ⬆️OS Naval Daver, M.D. #ASH21

✅ Another monoclonal antibodies in combinations with AZA-VEN 💡Magrolimab and IMGN632 in AML.. Looking forward for phase 3 trials showing ⬆️OS <a href="/Daver_Leukemia/">Naval Daver, M.D.</a> #ASH21
iman aboudalle (@imanaboudalle) 's Twitter Profile Photo

👍🏻Initial results of AZA-VEN-Gilt in FLT3m AML presented by Nicholas Short MD at #ASH21. Very encouraging 🤩 ORR=100% - MRDneg=86% - 6-mo OS=92% in frontline tx

👍🏻Initial results of AZA-VEN-Gilt in FLT3m AML presented by <a href="/NicholasShortMD/">Nicholas Short MD</a> at #ASH21. Very encouraging 🤩 ORR=100% - MRDneg=86% - 6-mo OS=92% in frontline tx
LBCI TV (@lbcilebanon) 's Twitter Profile Photo

برنامج "The Researcher " على الـLBCI... أبحاث رائدة من أجل مجتمع أفضل bit.ly/3gqqOqE #LBCILebanon #LBCINews

AML Hub (@aml_hub) 's Twitter Profile Photo

CONGRESS | #ASH23 | iman aboudalle American University of Beirut reports the impact of DNMT3A mutation on post-transplant outcomes in pts with AML patients receiving allo-HCT in first remission using #EBMT database. N=1374, DNMT3A mutant=46%. DNMT3A mutation negatively affects post-transplant

CONGRESS | #ASH23 | <a href="/ImanAboudalle/">iman aboudalle</a> <a href="/AUB_Lebanon/">American University of Beirut</a> reports the impact of DNMT3A mutation on post-transplant outcomes in pts with AML patients receiving allo-HCT in first remission using #EBMT database. N=1374, DNMT3A mutant=46%. DNMT3A mutation negatively affects post-transplant
iman aboudalle (@imanaboudalle) 's Twitter Profile Photo

📣Exciting news! 📣Thrilled to announce that our oncology fellowship program has been accredited by ACGME-I. This recognition underscores our commitment to excellence in cancer care and education. Huge thanks to everyone involved in achieving this milestone! 🎉 Faculty of Medicine #ACGMEI

📣Exciting news! 📣Thrilled to announce that our oncology fellowship program has been accredited by ACGME-I. This recognition underscores our commitment to excellence in cancer care and education. Huge thanks to everyone involved in achieving this milestone! 🎉 <a href="/AUB_FM/">Faculty of Medicine</a> #ACGMEI